Assertio Holdings Inc (ASRT)
0.848
+0.02
(+2.39%)
USD |
NASDAQ |
Apr 29, 16:00
0.85
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Cash from Financing (TTM): -44.20M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -44.20M |
September 30, 2023 | -36.08M |
June 30, 2023 | -33.19M |
March 31, 2023 | -24.30M |
December 31, 2022 | -7.794M |
September 30, 2022 | -14.52M |
June 30, 2022 | -17.76M |
March 31, 2022 | -17.89M |
December 31, 2021 | 29.03M |
September 30, 2021 | 28.58M |
June 30, 2021 | 18.70M |
March 31, 2021 | -63.97M |
December 31, 2020 | -468.55M |
September 30, 2020 | -480.56M |
June 30, 2020 | -524.61M |
March 31, 2020 | -489.50M |
December 31, 2019 | -157.84M |
September 30, 2019 | -163.06M |
June 30, 2019 | -108.66M |
March 31, 2019 | -110.15M |
December 31, 2018 | -81.35M |
September 30, 2018 | -68.68M |
June 30, 2018 | -68.89M |
March 31, 2018 | -112.21M |
December 31, 2017 | -110.89M |
Date | Value |
---|---|
September 30, 2017 | -99.01M |
June 30, 2017 | -97.63M |
March 31, 2017 | -99.61M |
December 31, 2016 | -100.17M |
September 30, 2016 | -105.23M |
June 30, 2016 | -103.19M |
March 31, 2016 | 564.81M |
December 31, 2015 | 568.10M |
September 30, 2015 | 577.20M |
June 30, 2015 | 910.64M |
March 31, 2015 | 348.51M |
December 31, 2014 | 347.22M |
September 30, 2014 | 585.44M |
June 30, 2014 | 249.87M |
March 31, 2014 | 246.59M |
December 31, 2013 | 243.88M |
September 30, 2013 | 3.057M |
June 30, 2013 | 2.321M |
March 31, 2013 | 2.626M |
December 31, 2012 | 2.686M |
September 30, 2012 | 2.31M |
June 30, 2012 | 1.972M |
March 31, 2012 | 5.198M |
December 31, 2011 | 6.054M |
September 30, 2011 | 5.133M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-524.61M
Minimum
Jun 2020
29.03M
Maximum
Dec 2021
-135.59M
Average
-36.08M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
Ocular Therapeutix Inc | 169.83M |
Cormedix Inc | 55.92M |
Verastem Inc | 134.19M |
Puma Biotechnology Inc | 0.00 |
CytomX Therapeutics Inc | 30.23M |